Updated Jul. 2, 2012 at 7:49 a.m.

Premium Lock Trial results accelerate potential blockbuster GSK respiratory drug

Published: 2012-07-02 07:39:00
Updated: 2012-07-02 07:49:30


Glaxo and partner Theravance began a collaboration a decade ago to develop respiratory drugs to help succeed Advair, Glaxo's aging best-seller....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2017 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders